Novel role of endothelial BKCa channels in altered vasoreactivity following hypoxia.
The systemic vasculature exhibits attenuated vasoconstriction following hypobaric chronic hypoxia (CH) that is associated with endothelium-dependent vascular smooth muscle (VSM) cell hyperpolarization. We hypothesized that increased activity of endothelial cell (EC) large-conductance, calcium-activated potassium (BK(Ca)) channels contributes to this response. Gracilis resistance arteries from hypobaric CH (barometric pressure = 380 mmHg for 48 h) rats demonstrated reduced myogenic reactivity and hyperpolarized VSM membrane potential (E(m)) compared with controls under normoxic ex vivo conditions. These differences were eliminated by endothelial disruption. In the presence of cyclooxygenase and nitric oxide synthase inhibition, combined intraluminal administration of the intermediate and small-conductance, calcium-activated K(+) channel blockers TRAM-34 and apamin was without effect on myogenic responsiveness and VSM E(m) in both groups; however, these variables were normalized in CH arteries by intraluminal administration of the BK(Ca) inhibitor iberiotoxin (IBTX). Basal EC E(m) was hyperpolarized in arteries from CH rats compared with controls and was restored by IBTX, but not by TRAM-34/apamin. K(+) channel blockers were without effect on EC basal E(m) in controls. Similarly, IBTX blocked acetylcholine-induced dilation in arteries from CH rats, but was without effect in controls, whereas TRAM-34/apamin eliminated dilation in controls. Acetylcholine-induced EC hyperpolarization and calcium responses were inhibited by IBTX in CH arteries and by TRAM-34/apamin in controls. Patch-clamp experiments on freshly isolated ECs demonstrated greater K(+) current in cells from CH rats that was normalized by IBTX. IBTX was without effect on K(+) current in controls. We conclude that hypobaric CH induces increased endothelial BK(Ca) channel activity that contributes to reduced myogenic responsiveness and EC and VSM cell hyperpolarization.
Hughes
Jennifer M
JM
Vascular Physiology Group, Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center,Albuquerque, New Mexico 87131-0001, USA.
Riddle
Melissa A
MA
Paffett
Michael L
ML
Gonzalez Bosc
Laura V
LV
Walker
Benjimen R
BR
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001030:Apamin / Q000494:pharmacology; D001158:Arteries / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D002118:Calcium / Q000378:metabolism; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D000860:Hypoxia / Q000378:metabolism* / Q000503:physiopathology*; D008297:Male; D023421:Models, Animal; D018408:Patch-Clamp Techniques; D010455:Peptides / Q000494:pharmacology; D026902:Potassium Channel Blockers / Q000494:pharmacology; D024681:Potassium Channels, Calcium-Activated / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology*; D014665:Vasodilator Agents / Q000494:pharmacology
D010455:Peptides; D026902:Potassium Channel Blockers; D024681:Potassium Channels, Calcium-Activated; D011720:Pyrazoles; C411671:TRAM 34; D014665:Vasodilator Agents; D001030:Apamin; C064719:iberiotoxin; D000109:Acetylcholine; D002118:Calcium
J Physiol. 2002 Dec 15;545(3):829-36
12482889
Am J Physiol Heart Circ Physiol. 2002 Dec;283(6):H2202-9
12388297
Circ Res. 2005 Oct 14;97(8):781-8
16166558
J Appl Physiol (1985). 1998 Aug;85(2):411-7
9688713
J Physiol. 2004 May 1;556(Pt 3):887-903
14966304
Am J Physiol. 1996 Mar;270(3 Pt 2):H1001-7
8780196
Br J Pharmacol. 2001 Nov;134(5):1021-8
11682450
Am J Physiol Heart Circ Physiol. 2003 Oct;285(4):H1590-9
12805022
J Physiol. 2007 Jun 1;581(Pt 2):445-56
17331986
J Biol Chem. 2005 Mar 25;280(12):11656-64
15665381
FASEB J. 2004 Jul;18(10):1080-9
15226268
Br J Pharmacol. 2003 Mar;138(6):1031-5
12684258
Circ Res. 2002 May 31;90(10):1108-13
12039801
Nature. 1998 Nov 19;396(6708):269-72
9834033
Lung. 2002;180(4):203-14
12391510
Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2908-15
11087247
J Physiol. 2002 Aug 1;542(Pt 3):929-37
12154190
Br J Pharmacol. 2005 Jul;145(6):775-84
15895105
Br J Pharmacol. 2005 Feb;144(4):477-85
15655533
Am J Physiol Heart Circ Physiol. 2001 Jul;281(1):H232-40
11406490
Am J Physiol Heart Circ Physiol. 2003 Mar;284(3):H838-45
12446283
Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1760-7
11959641
Am J Physiol Heart Circ Physiol. 2002 Jan;282(1):H30-7
11748044
Br J Pharmacol. 2003 Feb;138(4):594-601
12598413
Am J Physiol Heart Circ Physiol. 2003 May;284(5):H1655-61
12511430
Am J Physiol. 1998 Oct;275(4):R1025-30
9756530
Am J Physiol Cell Physiol. 2000 Feb;278(2):C235-56
10666018
Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H220-8
12637349
Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H127-36
12623785
J Physiol. 2003 Nov 15;553(Pt 1):183-9
14555724
Am J Physiol Lung Cell Mol Physiol. 2007 Nov;293(5):L1135-42
17693482
Acta Physiol Scand. 1995 Nov;155(3):257-66
8619323
Microcirculation. 2005 Mar;12(2):169-82
15824039
Cell Calcium. 2005 Jul;38(1):23-33
15907999
Gen Physiol Biophys. 1999 Jun;18(2):199-208
10517293
Am J Physiol Heart Circ Physiol. 2001 Jul;281(1):H298-307
11406497
Am J Respir Crit Care Med. 1997 Nov;156(5):1572-8
9372678
Am J Physiol. 1991 Jun;260(6 Pt 2):R1114-22
2058739
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8151-6
10884437
Am J Physiol Regul Integr Comp Physiol. 2002 Jul;283(1):R79-85
12069933
Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):28-38
11145930
Circ Res. 1996 Mar;78(3):415-23
8593700
Kidney Int. 2003 Jul;64(1):199-207
12787410
Microcirculation. 2005 Jan-Feb;12(1):113-27
15804979
Am J Physiol. 1999 Mar;276(3):H961-9
10070080
Microcirculation. 2006 Mar;13(2):81-8
16459321
Circ Res. 2000 Sep 15;87(6):474-9
10988239
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H216-22
16473954